Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03

This notice is for the conclusion of agreements with pharmaceutical companies in accordance with Section 130a (8) sentence 1 SGB V. The invitation to participate is addressed only to pharmaceutical companies or associations of pharmaceutical companies as defined in Section 4 (18) of the Medicinal Products Act. This is not an Open Procedure in accordance with Section 15 of the VgV in conjunction with Section 119 (3) of the GWB, but a publication of the invitation to conclude/join discount contracts with conditions fixed and non-negotiable for all participants, including the level of the discount. An unlimited number of pharmaceutical companies or associations of pharmaceutical companies as defined in Section 4 (18) of the Medicinal Products Act may become contracting parties.